APOE ε4, modifiable risk factors, and dementia in community‐based older Japanese adults
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-04 · 18 (2)
DOI: 10.1002/dad2.70371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 21.05.2026. Verfasst von Masaya Kumamoto und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Public Health Graduate School of Medical Sciences Kyushu University Fukuoka Japan. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Ministry of Health, Labour and Welfare.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Apolipoprotein E ( APOE ) ε4 is a major genetic risk factor for dementia. We examined whether APOE ε4 genotype modified the associations between a modifiable risk factor (mRF) score and dementia in older Japanese adults. METHODS This cross‐sectional study included 9605 community‐dwelling Japanese individuals aged ≥65 years. APOE ε4 genotype and mRF scores were assessed. Dementia was clinically diagnosed. Brain magnetic resonance imaging (MRI) measures were available in a subset. RESULTS The odds ratio (OR) for dementia increased with the number of APOE ε4 alleles. A low mRF score was associated with lower ORs for prevalent dementia in non‐carriers and heterozygotes but not in homozygotes. On MRI, low mRF scores were associated with preserved brain structure in non‐carriers and heterozygotes, but not in homozygotes. DISCUSSION Favorable risk factor profiles were associated with lower dementia risk and preserved brain structure in APOE ε4 non‐carriers and heterozygotes, but not in homozygotes, supporting genotype‐tailored prevention strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Public Health Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
- Department of Medicine and Clinical Science Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
- Center for Cohort Studies Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
- Department of Neuropsychiatry Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
- Department of Health Care Administration and Management Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
- Department of Aging Research and Geriatric Medicine Institute of Development Aging and Cancer Tohoku University Sendai Japan.
Förderung
- Japan Agency for Medical Research and Development
- Ministry of Health, Labour and Welfare
Zitieren
APA
Kumamoto, M., Ninomiya, T., Furuta, Y., Shibata, M., Ohara, T., Hata, J., Ago, T., Taki, Y., Mikami, T., Maeda, T., Ono, K., Mimura, M., Hanajima, R., Iga, J. I., Takebayashi, M., Momozawa, Y., & Japan Prospective Studies for Aging and Dementia (JPSC‐AD) Study Group# (2026). APOE ε4, modifiable risk factors, and dementia in community‐based older Japanese adults. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18(2). https://doi.org/10.1002/dad2.70371
Vancouver
Kumamoto M, Ninomiya T, Furuta Y, Shibata M, Ohara T, Hata J, et al. APOE ε4, modifiable risk factors, and dementia in community‐based older Japanese adults. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026;18(2). doi:10.1002/dad2.70371
BibTeX
@article{Kumamoto2026,
author = {Kumamoto, Masaya and Ninomiya, Toshiharu and Furuta, Yoshihiko and Shibata, Mao and Ohara, Tomoyuki and Hata, Jun and Ago, Tetsuro and Taki, Yasuyuki and Mikami, Tatsuya and Maeda, Tetsuya and Ono, Kenjiro and Mimura, Masaru and Hanajima, Ritsuko and Iga, Jun-Ichi and Takebayashi, Minoru and Momozawa, Yukihide and Japan Prospective Studies for Aging and Dementia (JPSC‐AD) Study Group#, Japan Prospective Studies for Aging and Dementia (JPSC‐AD) Study Group#},
title = {APOE ε4, modifiable risk factors, and dementia in community‐based older Japanese adults},
journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
year = {2026},
volume = {18},
number = {2},
doi = {10.1002/dad2.70371}
}
EUVIMED